Evidence method
Level · gp.fundamentals.capex_revenue_ratio
2.49% · OPTIONAL · VALID
GROSSPATTERN / FUNDAMENTAL STATE / POINT IN TIME
UTMD · Jun 30, 2023
UTAH MEDICAL PRODUCTS INC. A multidimensional configuration derived from the filing available at this observation—never a composite score or recommendation.
STATE CAPABILITYLEVEL 3[email protected]
Inspectable configuration
State dimensions
Filing0001811884-23-000017General Corporate
Evidence method
Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue
38.19% · OPTIONAL · VALID
Evidence method
Yoy · gp.fundamentals.revenue
-4.19% · CORE · VALID
Evidence method
Level · gp.fundamentals.inventory_revenue_ratio
78.63% · OPTIONAL · VALID
Evidence method
Level · gp.fundamentals.gross_margin
60.15% · CORE · VALID
Evidence method
Level · gp.fundamentals.operating_margin
34.39% · CORE · VALID
Evidence method
Ratio · gp.fundamentals.rnd + gp.fundamentals.revenue
1.03% · OPTIONAL · VALID
Evidence method
Level · gp.fundamentals.sbc_revenue_ratio
0.39% · OPTIONAL · VALID
As-filed lineage
Fundamental state history
Each observation is tied to the filing and facts available at that report date. Amendments remain separate.
History29 statesSelf-history eligible
Dec 31, 20217/9 normalizedLevel 3Mar 31, 20227/8 normalizedLevel 3Jun 30, 20227/8 normalizedLevel 3Sep 30, 20228/8 normalizedLevel 3Dec 31, 20228/9 normalizedLevel 3Dec 31, 20228/9 normalizedAmended as filedMar 31, 20238/8 normalizedLevel 3Jun 30, 20238/8 normalizedLevel 3Sep 30, 20238/8 normalizedLevel 3Dec 31, 20238/9 normalizedLevel 3Mar 31, 20248/8 normalizedLevel 3Jun 30, 20248/8 normalizedLevel 3Sep 30, 20248/8 normalizedLevel 3Dec 31, 20248/9 normalizedLevel 3Mar 31, 20258/8 normalizedLevel 3Jun 30, 20258/8 normalizedLevel 3Sep 30, 20258/8 normalizedLevel 3Dec 31, 20258/9 normalizedLevel 3Mar 31, 20268/8 normalizedLevel 3Jun 30, 20268/8 normalizedLevel 4
Period transition
What moved in the state?
- Previous
- 0.34%
- Current
- 2.49%
- Delta
- 2.14%
- Previous
- 55.23%
- Current
- 38.19%
- Delta
- -17.05%
- Previous
- 1.60%
- Current
- -4.19%
- Delta
- -5.78%
- Previous
- 79.39%
- Current
- 78.63%
- Delta
- -0.76%
- Previous
- 62.64%
- Current
- 60.15%
- Delta
- -2.49%
- Previous
- 35.46%
- Current
- 34.39%
- Delta
- -1.06%
- Previous
- 1.15%
- Current
- 1.03%
- Delta
- -0.12%
- Previous
- 0.40%
- Current
- 0.39%
- Delta
- -0.01%
Self-history only
Previous similar states
Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.
Not enough compatible prior states for a transparent self-history match.
Research Graph
Related governed research
Transitioned To · UTMD Fundamental State →Analogous To · UTMD state analogue 1 →Has State · UTAH MEDICAL PRODUCTS INC →Transitioned To · UTMD Fundamental State →Transitioned To · UTMD CAPEX_INTENSITY_INCREASED →Transitioned To · UTMD CASH_GENERATION_DECREASED →Transitioned To · UTMD GROWTH_DECREASED →Transitioned To · UTMD INVENTORY_PRESSURE_DECREASED →Transitioned To · UTMD MARGIN_DECREASED →Transitioned To · UTMD PROFITABILITY_DECREASED →Transitioned To · UTMD R_AND_D_INTENSITY_DECREASED →Transitioned To · UTMD SBC_INTENSITY_DECREASED →
Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.